DENTIS CO.,LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9,360 KRW | +0.54% |
|
+4.12% | +3.20% |
| 2023 | DENTIS CO.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
| 2021 | Dentis Co.,Ltd(KOSDAQ:A261200) added to S&P Global BMI Index | CI |
| Sales 2022 | 87.09B 63.4M 86.65M | Sales 2023 | 94.33B 68.68M 93.86M | Capitalization | 138B 101M 137M |
|---|---|---|---|---|---|
| Net income 2022 | 1.23B 895K 1.22M | Net income 2023 | 3.84B 2.79M 3.82M | EV / Sales 2022 | 1.79 x |
| Net Debt 2022 | 40.1B 29.19M 39.9M | Net Debt 2023 | 59.62B 43.4M 59.32M | EV / Sales 2023 | 2.1 x |
| P/E ratio 2022 |
94.5
x | P/E ratio 2023 |
34.5
x | Employees | 378 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 67.08% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.54% | ||
| 1 week | +4.12% | ||
| Current month | +1.74% | ||
| 1 month | +3.43% | ||
| 3 months | +5.64% | ||
| 6 months | +10.25% | ||
| Current year | +3.20% |
1 week
9 040.00
9 500.00
1 month
8 630.009 500.00
Current year
8 450.0011 900.00
1 year
8 010.0015 990.00
3 years
6 750.0016 100.00
5 years
6 750.0017 250.00
10 years
6 750.0017 250.00
| Managers | Title | Age | Since |
|---|---|---|---|
Ki-Bong Sim
CEO | Chief Executive Officer | 55 | - |
Sang-Yong Choi
BRD | Director/Board Member | 54 | - |
Hyung Sim
BRD | Director/Board Member | 54 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ki-Bong Sim
CEO | Chief Executive Officer | 55 | - |
Hyung Sim
BRD | Director/Board Member | 54 | - |
Sang-Yong Choi
BRD | Director/Board Member | 54 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-28 | 9,360 | +0.54% | 109 147 |
| 24-04-26 | 9,310 | +1.42% | 65,299 |
| 24-04-25 | 9,180 | -0.22% | 44,120 |
| 24-04-24 | 9,200 | +0.22% | 65,580 |
| 24-04-23 | 9,180 | +0.88% | 56,651 |
End-of-day quote Korea S.E., April 28, 2024
More quotes
Dentis Co Ltd is a Korea-based company primarily engaged in the manufacture and sale of medical devices. The Company is engaged in the manufacture and sale of dental implant products, dental 3D printers, biomaterials and other products. In addition, the Company is engaged in the manufacture and sale of prosthetics, surgical instruments and other products.
Calendar
2024-05-22
- Q1 2024 Earnings Release (Projected)
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +3.20% | 103M | |
| +12.93% | 128B | |
| -8.76% | 10.65B | |
| +3.60% | 8.82B | |
| +19.19% | 7.19B | |
| +22.05% | 4.99B | |
| +7.65% | 3.4B | |
| -0.21% | 3.03B | |
| -4.80% | 2.14B | |
| -4.72% | 2B |
- Stock Market
- Equities
- A261200 Stock
